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Recent Research on Nickel
Carcinogenesis
by F. William Sunderman, Jr.*
Research on nickel carcinogenesis from 1975 to March 1980 is reviewed. Epidemiological
studies have strengthened the evidence that workers in nickel refineries have increased risks of
cancers of the nasal cavities and lungs. Clinical investigations have resulted in improved
diagnosis, classification, and management of cancers of respiratory organs in nickel refinery
workers. Carcinogenicity tests have demonstrated the carcinogenicity of nickel subsulfide
(a-Ni3S2) in rodents following administration by a variety of parenteral routes. Radiotracer
studies and x-ray diffractometry have clarified the metabolism of a-Ni3S2 in rodents. In vitro
exposures of mammalian cells to certain nickel compounds have been shown to inhibit cellular
uptake of thymidine-3H, and to induce chromosomal aberrations, somatic mutations, and
morphological transformation. Mutagenicity tests ofnickel compounds in bacterial systems have
consistently been negative. Ni(II) has been reported to impair the fidelity ofviral and bacterial
DNA polymerases for in vitro replication of synthetic nucleotide templates.
Introduction
Research on nickel carcinogenesis prior to 1975
has been comprehensively reviewed and critically
evaluated by panels of scientific experts under the
auspices ofthe U.S. National Academy ofSciences
(NAS) (1) and the International Agency for Re-
search on Cancer (IARC) (2). Both scientific panels
concluded that increased incidences of lung cancer
and nasal cancer have been demonstrated by epi-
demiological studies ofnickel refinery workers, and
that the carcinogenicity ofcertain nickel compounds
has been definitely established by animal experi-
ments (1, 2). In 1977, the U.S. National Institute of
Occupational Safety and Health (NIOSH) stated
that "An excess number ofdeaths from lung cancer
and nasal cancer has been observed in nickel
refinery workers. After review of the relevant
data, it was concluded that a substantial portion of
those excess deaths was caused by exposure to
airborne nickel compounds" (3). Readers are re-
ferred tothe NAS, IARC, and NIOSH monographs
(1-3) and to several review articles (4-9) for the
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scientific background on nickel carcinogenesis. Rel-
evant investigations from 1975 to March 1980 are
summarized in the present article, so that readers
may be informed about the many recent develop-
ments in nickel carcinogenesis. Emphasis is placed
upon new experimental techniques to study nickel
carcinogenesis in vivo and in vitro, and attention is
focused upon prospects for future research on the
mechanism(s) whereby nickel compounds initiate
neoplastic transformation.
Epidemiological Studies
Several recent studies have analyzed the risks of
respiratory tract cancers in workmen who have
been exposed to inhalation of nickel compounds
(10-15). Doll et al. (10) reinvestigated the causes of
death ofemployees at a nickel refinery in Clydach,
Wales, U.K. based upon a cohort of 967 men who
began working before 1945. As shown in Table 1,
men who entered employment prior to 1930 had
excess risks of respiratory tract cancer. Pedersen
et al. (11) reported a similar updated survey of
mortality from respiratory cancers in workers at a
nickel refinery in Kristiansand, Norway. Increased
risks of cancers of the nasal cavities, lung and
larynx occurred in a cohort of 2249 men who
131worked at the refinery for at least 3 years prior to
1953. Twenty cases of nasal cancer were observed
(0) versus0.81expected(E)(O/E = 24.7);69casesof
lung cancer were observed versus 18.64 expected
(O/E = 3.7), and 6 cases of larynx cancer were
observed versus2.11 expected(O/E = 2.8). Workers
in the roasting, smelting, and electrolysis depart-
ments of the nickel refinery had the highest inci-
dence rates for cancers of respiratory organs.
Kreyberg (12) studied the characteristics of lung
cancers in workmen at the same nickel refinery in
Kristiansand, Norway. A tabulation of 39 lung
cancers included 26 epidermoid (squamous cell)
carcinomas, 6 small cell anaplastic carcinomas, and
7 adenocarcinomas (including related histological
types). Based upon detailed analyses of work
chronologies and smoking histories, Kreyberg (11)
concluded that tobacco smoking contributed to the
development of lung cancers in the nickel-exposed
workers. Lessard et al. (13) studied the influence of
nickel exposure upon lung cancer mortality in
Noumea, New Caledonia. Workers at a nickel
refinery had three-fold risk of lung cancer, inde-
pendent ofthe effects ofage and cigarette smoking.
Lung cancer risk was also increased three-fold in
persons who lived in a zone less than 1 km from the
nickel refinery, in comparison to persons who lived
more than 3 km from the refinery. This excess risk
was independent of employment in the refinery.
Bernacki et al. (14) assessed the possible associa-
tion between exposure to nickel-containing com-
pounds and lung cancer mortality in workmen at an
aircraft engine factory in Hartford, Connecticut,
U.S.A. This case-control study was limited to men
who died prior to retirement from work, and hence
the possible latent period for development of lung
cancer was restricted. The 42 nickel-exposed dece-
dents comprised welders, electroplaters, metal-
powder sprayers, grinders, polishers, and bench
mechanics, and the 84 control decedents comprised
workers in other factory trades who had minimal
occupational exposures to nickel. The proportions
of deaths from lung cancer were equal in the
nickel-exposed decedentsandinthecontrols. Godbold
and Tompkins (15) performed a case-control study
of mortality from respiratory cancer in 814 white
men who had been employed prior to 1954 in the
barrier department of a gaseous diffusion plant in
Oak Ridge, Tennessee, U.S.A. The workers used
nickel powder to fabricate a porous barrier for
isotopic enrichment of uranium by gaseous diffu-
sion. The control group included 1600 white men
who worked in other departments and who had no
record ofnickel exposure. Employees and pension-
ers were traced for a minimum follow-up period of
19 years. The nickel-exposed cohort experienced
lower mortality than the controls, both in deaths
from respiratory cancer and in deaths from all
causes, but neither ofthese differences was statis-
tically significant (15).
Clinical Investigations
Recent advances in diagnosis, classification, and
management of cancers of the nasal cavities and
lungs in nickel refinery workers have been de-
scribed in clinical reports (16-23). Nelen et al. (16)
conducted a prospective study of sputum cytology
in 268 asymptomatic men who had been employed
prior to 1963 inthe sinteringdepartment of a nickel
refineryin Sudbury, Ontario, Canada. Eleven cases
of lung cancer and one case of laryngeal cancer
were discovered. Nelen et al. (16) concluded that
prospective cytologic screening of sputum for neo-
plastic cellsis an effectivetechnique fordetection of
cancers of the respiratory tract in nickel refinery
workers. They also noted that 11 ofthe 12 subjects
with respiratory tract cancers were smokers and
that the remaining subject was a former smoker
(16). Barton (17) summarized the results of a cancer
Table 1. Deaths from respiratory tract cancers in a cohort of workmen at a nickel refinery in Clydach, Wales.a
Deaths from cancer of the nasal sinusesb Death from cancer of the lungb
Year of first employment oc E O/E 0 E O/E
< 1910 14 0.036 389 24 2.389 10.0
1910-1914 24 0.037 649 34 3.267 10.4
1915-1919 11 0.025 440 20 3.070 6.5
1920-1924 7(1) 0.071 99 50 9.642 5.2
1925-1929 0(1) 0.026 0 9 3.613 2.5
1930-1944 0 0.034 0 8 5.463 1.5
aData of Doll et al. (10).
bo = observed deaths based upon death certificates; E = expected deaths based upon national mortality rates; O/E = ratio of
observed to expected deaths.
COases of nasal sinus cancer referred to as an associated cause of death are shown in parentheses.
132 Environmental Health Perspectivesdetection program forapproximately 1200workmen
at a nickel refinery in Kristiansand, Norway. The
program consisted of periodic physical examina-
tions (including rhinoscopy), x-ray examinations of
the chest and nasal sinuses, and analyses of nickel
concentrations in plasma and urine. In selected
cases, sputum cytology and nasal mucosal biopsy
were performed. During 5 years of surveillance,
nearly 100 employees with suspicious signs or
symptoms were subjected to nasal mucosal biop-
sies. The biopsies yielded the following significant
findings: 4 cases ofinvasive squamous cell carcino-
ma, 2 cases of carcinoma in situ, and 16 cases of
epithelial atypia. Fifteen of these subjects had
worked in the roasting-smelting department ofthe
nickel refinery. Barton (17) discussed the manage-
ment ofnasal cancers innickelrefineryworkers and
he recommended radical surgical resection, alone,
or in combination with postoperative radiation
therapy. Torjussen and co-workers (18-23) evaluat-
ed the rhinoscopic appearance, x-ray findings,
histopathologic lesions, and nickel concentrations in
body fluids and nasal biopsies of active and retired
workers at the same nickel refinery in Kristiansand,
Norway. Nasal polyps and hyperplastic rhinitis
were more common in the nickel refinery workers
than in controls, but no significant differences were
observed between x-ray findings in nasal sinuses of
nickel-exposed and control subjects (18). Histo-
pathologic changes in nasalbiopsies from active and
retired nickel refinery workers and from controls
were scored numerically, andthe scores werefound
to correlate with duration of nickel exposure, type
of nickel exposure, and tobacco consumption. Two
workers from the roasting-sintering department,
both employed 28 years at the nickel refinery, had
nasalcarcinomas. Epithelialdysplasia, anapparently
precancerous lesion, was found in 38 of 318 active
and 7 of 15 retired nickel workers, and in only 1 of
57controls(19,20).*Increasednickelconcentrations
were found in nasal biopsy specimens from all
categories ofnickel-exposed workers, but the high-
est concentrations were found in workers from the
roasting-smelting department (21). Analyses of
nickel concentrations in nasal biopsy specimens
from pensioned workers showed that accumulated
nickel was retained for several years aftertermina-
tion of nickel exposure, and was slowly released
fromthe nasalmucosa with an estimated half-life of
3.5 years (21). Attempts to identify the cellular
localization of nickel in nasal biopsy specimens by
histochemical staining methods and by energy dis-
*In view ofthe propensity ofwood-workers to develop nasal
cancer, it is noteworthy that the control subject with epithelial
dysplasia was a carpenter.
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persivex-raymicroanalysiswereinconclusive, owing
to insufficient analytical sensitivity (22, 23).
Sunderman (24) reported an unusual case ofpolyp-
oid squamous cell carcinoma of the nose in a
36-year-old man. The patient had worked in a
cutlery factory for 12 years. For several years, he
had immersed small nickel-plated objects (such as
teapots) in a tank ofHCI-HNO3 at 85°C in order to
remove old nickel plating (e.g., from battered hotel
utensils). During this operation, the patient had
chronically inhaled nickel-containing acid fumes
from the nickel-stripping tank. In view of the
patient's relative youth and occupational history,
Sundernan (24) suspected that the patient's nasal
cancerwas causedbynickel. Bourasset and Galland
(25) previously reported a similar case of nasal
cancerin acutleryworkerwho had been exposed to
inhalation of nickel-containing fumes.
Carcinogenicity Tests in Animals
In order to bring up to date the IARC mono-
graph on nickel and nickel compounds (2), this
resume of recent tests of the carcinogenicity of
nickel compounds in experimental animals is
patterned on the IARC format.
Inhalation and/or Intratracheal
Administration
Saknyn and Blohkin (20) exposed nonpedigree
albino rats to inhalation of feinstein dust (an
intermediate product ofnickel refining, which con-
tains NiS, NiO, and metallic Ni) in atmospheric
concentration of 70 mg dust/m3 for 5 hr/day, 5
days/week during 6 months. Lung cancers (squa-
mous cell carcinomas) were found in 2 of5 rats that
survived the treatment. The latent period for
tumor development was 17 months. Saknyn and
Blohkin (20) also administered black nickel monox-
ide (NiO) to albino rats as a single intratracheal
injection (20 to 40 mg/rat). Lung cancer (squamous
cell carcinoma) developed in 1 of 26 rats after a
latent period of 17 months. No lung tumors were
found in an untreated control group of 47 rats.
Mukubo (27) treated female albino rats by a
single intratracheal injection ofmetallic nickel dust
(10 mg/rat), alone, or in combination with methyl-
cholanthrene (5 mg/rat). At 12 weeks, lung cancers
(squamous cell carcinomas) were seen in (a) 3 of 5
rats that received nickel plus methylcholanthrene;
(b) 2 of 7 rats that received methylcholanthrene
alone, and (c) 0 of7 rats that received nickel alone.
The failure to detect lung cancers in the nickel-
treated group should not be considered a negative
133carcinogenicity test, owing to the short period of
observation.
Yarita and Nettesheim (28) studied the carcino-
genicity ofnickel subsulfide (a-Ni3S2) inheterotopic
tracheas that were transplanted (two tracheas/rat)
underthe dorsal skin ofisogeneic female rats ofthe
Fischer strain. Gelatin pellets were inserted into
the transplanted tracheas at4weeks aftergrafting.
Sixty tracheas received pellets that contained 1 mg
of a-Ni3S2; 64 tracheas received pellets that con-
tained 3 mg of a-Ni3S2, and 10 control pellets
received gelatin pellets, alone. Surviving rats were
killed after20 months. At the 1 mgdose ofa-Ni3S2,
tumors developed in 9/60 tracheas (5 squamous cell
carcinomas, 1 undifferentiated carcinoma, 2
fibrosarcomas, and 1 leiomyosarcoma). At the 3 mg
dose ofa-Ni3S2, tumors developed in45/64 tracheas
(1 squamous cell carcinoma, 12 fibrosarcomas, 10
leiomyosarcomas, 10 fibromyosarcomas, 2 rhabdo-
myosarcomas, 2 fibromyxosarcomas, 7 sarcomas of
uncertain type, and 1 benign myoma). No tumors
developed in the 10 control tracheas.
Oral Administration
Sunderman et al. (29) painted a-Ni3S2 in glycerol
onto the buccal pouch mucosa of four groups of
Syrian golden hamsters of the LVG/LAK strain.
The dosage schedules were: (a) 1 mg a-Ni3S2, 3
times/week for 18 weeks in 6 hamsters; (b) 2 mg
a-Ni3S2, 3 times/week for 18 weeks in 7 hamsters;
(c) 5 mg a-Ni3S2, 3 times/week for 36 weeks in 15
hamsters; and (d) 10 mg a-Ni3S2, 3 times/week for
36 weeks in 13 hamsters. Surviving hamsters were
killed at 24 months after the initial application. No
tumors were found in the buccal pouch, oral cavity
or gastrointestinal tract of any of these hamsters,
orin 15 controls thatreceived buccal pouch applica-
tions of the glycerol vehicle (0.2 ml, 3 times/week
for 36 weeks). Cancers (squamous cell carcinomas)
ofthe buccal pouch were found in 4/4 hamsters in a
positive controlgroup thatreceived similar applica-
tions of dimethylbenzanthracene in glycerol (1 mg
DMBA, 3 times/week for 18 weeks).
Intramuscular Injection
Sunderman (30) administered a-Ni3S2 to albino
mice ofboth sexes by a single IM injection (2.5 mg
a-Ni3S2/mouse). Within 100weeks, sarcomas devel-
oped at the injection site in 6/9 mice ofthe DBA-2
strain (versus 0/9 vehicle controls) and in 5/10 mice
ofthe C57-BL6 strain (versus 0/9 vehicle controls).
Sunderman et al. (31)gave single IMinjections of
six nickel compounds in equal doses (14 mg Ni/rat)
to male Fischer rats. This experiment was a
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supplement to an earlier study (32) that was
included in the 1976 IARC monograph (2). By 100
weeks after the IM injection, the incidences of
sarcomas at the injection sites were: (a) metallic Ni
dust: 13/20 rats; (b) crystalline nickel subselenide
(Ni3Se2):21/23rats;(c)crystallinenickelmonoselenide
(NiSe): 8/16 rats; (d) crystalline nickel subsulfide
(ot-Ni3S2): 9/9rats; (e) crystalline nickelmonosulfide
(,-NiS): 14/14rats; (f)amorphousnickelmonosulfide
(NiS): 0/10 rats; and (g) vehicle controls: 0/44 rats.
Based upon the marked differences in sarcoma
incidences afteran IM injection ofcrystalline P-NiS
and amorphous NiS, Sunderman et al. (31) conclud-
ed that the physical form of nickel sulfides has a
critical influence upon their carcinogenic activities.
In the same experiment, sarcomas were observed
at the injection site in 3/16 rats that received a
lower dose (7 mg Ni/rat) of nickel carbonyl-
cyclopentadiene dimer; [Ni(CO)2(C5H5)2]2.
Sunderman (30) derived a dose-response curve
for induction of sarcomas in male Fischer rats by
single IM injection of ot-Ni3S2, based upon four
published and two previously unpublished experi-
ments which involved a total of 383 rats. The
experiments were all terminated at 100 to 104
weeks after the injection. Sarcoma incidence at 62
weeks afterthe injection was linearly related to the
reciprocaloftheo-Ni3S2dose, andranged from24%
(7/29) in rats that received 0.63 mg of a-Ni3S2, to
100% (9/9) in rats that received 20 mg of a-Ni3S2.
There was no indication ofa threshold carcinogenic
dosage in this experimental system. The histologic
types of336 sarcomas induced by an IM injection of
a-Ni3S2 included 161 rhabdomyosarcomas, 91
undifferentiated sarcomas, 72 fibrosarcomas, 9
liposarcomas, 2 neurofibrosarcomas, and 1 hemangio-
sarcoma. Metastases were found in41% (137/336) of
tumor-bearing rats.
Sunderman et al. (33) gave male Fischer rats a
single IMinjection ofa-Ni3S2 (1.2mg/rat), alone, or
incombinationwithmetallic Mndust (1.0mg/rat) or
metallic Crdust(1.0mg/rat). Within 100weeks, the
sarcomaincidence inratsthatreceived onlya-Ni3S2
was 22/30. Addition ofMn dust to a-Ni3S2 reduced
the sarcoma incidence to 1/14, whereas addition of
Cr dust to a-Ni3S2 did not affect the sarcoma
incidence (12/15). No sarcomas developed at the IM
injection site in three control groups, including 39
rats that received the injection vehicle, 14 rats that
received Mn dust alone (1.0 mg/rat), and 15 rats
that received Cr dust alone (1.0 mg/rat).
Sunderman (29) administered a-Ni3S2 to male
Syrian golden hamsters ofthe LVG/LAK strain by
a single IM injection. By 24 months after the
injection, theincidence oflocal sarcomas was 5/15in
hamsters that received 5 mgofa-Ni3S2 and 12/17 in
Environmental Health Perspectiveshamstersthatreceived 10mgofa-Ni3S2. Metastases
were found in 10 sarcoma-bearing hamsters. No
sarcomas occurred at the injection site in 14 control
hamsters that received an IM injection ofthe NaCI
vehicle.
Hildebrand and Biserte (34, 35) described 16
sarcomas (includingunspecified numbers ofrhabdo-
myosarcomas, fibrosarcomas, and3leiomyosarcomas)
that developed in albino rabbits at the site of IM
implantationofa-Ni3S2inagar(80mga-Ni3S2/rabbit).
These papers were concerned primarily with the
ultrastructural features of the tumors. The num-
bers oftreated and controlrabbitswerenotspecified.
Intraperitoneal Injection
Stoner et al. (36) and Shimkin et al. (37) de-
scribed an experiment in which nickelous acetate
was administered to 3 groups of strain A mice (20
mice/group) by IP injection, 3 times/week for 8
weeks, for total dosages of72, 180, and 360 mg/kg,
respectively. A control group was given similar IP
injections ofthe vehicle. The mice were killed at 30
weeks afterthe first injection. The average number
of lung tumors/mouse was 0.42 in controls, 0.67 at
the 72 mg/kg dose; 0.71 at the 180 mg/kg dose, and
1.26 at the 360 mg/kg dose. At the highest dose
level, the increase in lung tumors was statistically
significant.
Saknyn and Blokhin (26) treated albino rats by
single IP injection of feinstein dust at a dosage of
90-150 mg dust/rat. Sarcomas developed at the
injection site in 6 of39 rats after latent periods of6
to 15 months.
Intrarenal Injection
Jasminand associates (38, 39)administereda-Ni3S2
to female Sprague-Dawley rats by intrarenal (IR)
injection in dosage of 10 mg/rat. In three separate
experiments, cancer of the injected kidney devel-
oped in 7/16, 11/24, and 11/20 rats, respectively,
within 12 months. In contrast, renal cancers did not
develop in two control groups of 20 and 16 rats
which received IR injection ofthe vehicle, or in two
groups of18and 20rats whichreceived IR injection
of either metallic Ni dust or NiS (10 mg/rat). The
renaltumorsina-Ni3S2-treated ratswereallclassified
as carcinomas, although many of the tumors were
pleomorphic and included anaplastic spindle-cell
varieties. Jasmin and Solymoss (39) mentioned
unsuccessful attempts to induce renal tumors in
mice, hamsters and rabbits by IR injection of
a-Ni3S2, but they did not furnish experimental
details.
Sundernanetal. (40)alsotestedthecarcinogenicity
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ofa-Ni3S2 following IR injection in rats. Tumors of
the injected kidneydeveloped within2years in 9/32
Fischerrats (14 female, 18 male) that received 5mg
of a-Ni3S2, and in 23/38 rats (14 female, 24 male)
that received 10 mg of a-Ni3S2. No renal tumors
occurred in 52 control Fischer rats (17 female, 35
male) that received IR injection of the NaCl vehi-
cle. Injection IR ofa-Ni3S2 (5mg/rat) inducedrenal
tumors in 6/12 NIH black rats (6 female, 6 male),
and 7/11 Wistar-Lewis rats (6 female, 5 male). In
contrast, no renal tumors developed in 12 a-Ni3S2-
treated Long-Evans rats (6 female, 6 male). In
male Fischer rats that received an IR injection of
a-Ni3S2 (10mg/rat) combined withmetallic Mn dust
(7 mg/rat), the incidence ofrenal tumors was 17/28,
which differed significantly from the corresponding
incidencesof18/24 and0/23inmale Fischerratsthat
received IR injections ofa-Ni3S2 (10 mg/rat) alone
or Mn dust (7 mg/rat) alone. The 54 renal tumors
that were observed by Sunderman et al. (40) in
a-Ni3S2-treated rats were all malignant, and
metastases were found in 37/54 tumor-bearing rats.
The authors were uncertain whether the renal
cancers were epithelial or mesenchymal in origin
(40).
Intratesticular Injection
Damjanov et al. (41) administered a-Ni3S2 to
male Fischer rats by single intratesticular injection
(10 mg ot-Ni3S2/rat). Within 20 months, malignant
testicular neoplasms developed in 16 of 19 a-Ni3S2-
treated rats, and in 0 of 18 controls that received
intratesticular injection of NaCl vehicle. The tes-
ticularneoplasms in a-Ni3S2-treated rats included 4
fibrosarcomas, 4 fibrous histiocytomas, and 4
rhabdomyosarcomas. Metastases were identified in
4/16 tumor-bearing rats.
Intraocular Injection
Albert et al. (42) injected a-Ni3S2 (0.5 mg/rat)
into the vitreous cavity ofthe right eye ofjuvenile
male Fischer rats (1 month old). Malignant ocular
tumors developed in 14 of 15 treated rats by 8
months, and in 0 of 11 controls which received an
intraocular injection of NaCl vehicle. In three
a-Ni3S2-treated rats, the injected eye had two
primary tumors, and in two a-Ni3S2-treated rats,
the injected eye had three distinct primary tumors.
The 22 ocular neoplasms included 11 amelanotic
uveal melanomas, 4 retinoblastomas, 3 gliomas, 1
fibrosarcomaand 1phakocarcinoma, and3unclassified
malignant tumors. Extraocular extension, invasion
ofthe optic nerve, and metastases to lungand brain
were noted.
135Intracerebral Injection
Sosinski (43) injected nickelic oxide (Ni2O3) into
the cerebral cortex of 20 Wistar rats (10 male, 10
female) in adosage of3 mg Ni2O3/rat. Each rat also
received an im injection of Ni2O3 (10 mg/rat) into
the left gastrocnemius muscle. Control rats were
not mentioned. Cerebral gliomas were observed in
two rats that were killed at 14 and 21 months,
respectively, and a meningioma was found in one
rat that was killed at 21 months. No neoplasms
developed at the sites of IM injection of Ni2O3.
Other Parenteral Routes
Jasmin and Solymoss (39) mentioned that IV
administration of a-Ni3S2 (10 mg/rat) to 20 female
Sprague-Dawley rats did not increase the incidence
ofbenign ormalignant tumors, andthatintrahepatic
administration of a-Ni3S2 (10 mg/rat) to eight fe-
male Sprague-Dawley rats did not induce any
hepatic tumors. The periods of observation were
not specified. Sunderman et al. (29) reported that
no hepatic tumors developed in 13 male Fischer
rats that received an intrahepatic injection of
a-Ni3S2 (5 mg/rat), nor did any salivary gland
tumors develop in 11 male Fischer rats that re-
ceived an injection of a-Ni3S2 (2.5 mg/rat) into a
submaxillary gland. The periods of observation
were 2 years (29).
Relevant Experiments in Animals
X-Ray Diffractometry and Radiotracer
Studies
The metabolism of a-Ni3S2 in rodents has been
investigated by x-ray diffractometry (44, 45) andby
radiotracer studies (33, 44-46). Applications of
nickel radioisotopes in biological research have
recentlybeencomprehensively reviewedbyKasprzak
and Sunderman (47). These authors emphasized
that 'Ni is an ideal radioisotope for investigations
ofmetal carcinogenesis, because 63Ni is available in
highspecific activity(upto3.87kCi/g-atom) and has
a long half-life (92 years). Moreover, the soft beta
emission of 53Ni (67 keV) is readily counted by
liquid scintillation spectrophotometry, and it pro-
vides autoradiograms with exceptionally high reso-
lution. Kasprzak (46) administered a-Ni3S2 that
was radiolabeled with 'Ni or35S to Fischer rats by
IM injection in both hind limbs (10 mg/injection).
Local sarcomas developed in 8/8 a-3Ni3S2-treated
rats and in 4/7 a-Ni3"5S2-treated rats during 8
months of observation. Tumors developed at one
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injection site in5/15 rats, and atboth injection sites
in 7/15 rats. The tumors were all pleomorphic
rhabdomyosarcomas. Autoradiography showed ex-
tracellular particles ofa63Ni3S2 and cNi335S2 at the
injection sites. Theparticles ofradiolabeled a-Ni3S2
eventuallybecame surrounded byneoplastictissue.
Intracellular localization of Ni or S was not
detected within muscle or tumor cells, but sparse
a-3Ni3S2 particles were seen within macrophages
at the injection sites (46).
Sunderman et al. (33) elucidated the metabolism
of 'Ni following single IM injection ofa-3Ni3S2 in
10 male Fischer rats (1.2 mg/rat). The cumulative
excretions of N3Ni during8weeks aftertheinjection
averaged 67 (S.D. + 2) % in urine and 7 ± 2 % in
feces. At 2 to 10 weeks after IM injection of
a-Ni3S2, the particles ofa-Ni3S2 which remained at
the injection site were predominantly intracellular,
and were located primarily within cytoplasmic
vesicles in fibroblasts and macrophages. Residual
'Ni at the injection site averaged 19 ± 4% of the
dose in rats killed at20 to 24 weeks, and 14 ± 2% of
the dose in rats killed at 31 weeks after the
injection. Whole-body 'Nikineticparameterswhich
were computed by compartmental analysis were
not affected by admixture of Mn dust based upon
measurements of'Ni inurine, feces, injection site,
and viscera ofrats that received an IM injection of
a-63Ni3S2(1.2mg/rat), alone, orincombinationwith
Mn dust (1.0 mg/rat). However, the subcellular
distribution of 'Ni derived from a-3Ni3S2 was
significantly changed by admixture ofMn dust (33).
63Ni concentrations in ultrafiltrates of supernatant
fractions ofhomogenates ofinjection sites averaged
2.8 ± 0.7 ng/ml at 20 to 24 weeks after injection of
a-63Ni3S2plus Mndust, versus5.4 ± 2.0ng/mlafter
injection of only a-63Ni3S2.
Oskarsson et al. (45) administered a-6Ni3S2 or
a-Ni33S2 to NMRI mice by an IM or SC injection
(10 mg/mouse). During the period from 2 to 14
months after the injection, local sarcomas devel-
oped in 11/16 mice that received a SC injection of
a-Ni3S2 labelled with 'Ni or 'S, and in 8/16 mice
that received a similar IM injection of a-Ni3S2. In
the tumors, radiolabelled particles ofa-Ni3S2 were
mostly intracellular within fibroblasts and macro-
phages. X-ray diffractometry ofthe insoluble resi-
due from lyophillized tumor tissue did not reveal
a-Ni3S2, but distinctly demonstrated crystalline
a-Ni7S6 and P-NiS. Whole-body autoradi raphy
showed gradual mobilization ofsolubilized Ni and
'S from the injection site. There was also mobiliza-
tion of nonsolubilized 'Ni-labeled particles, which
were located withinphagocytesinliver, spleen, and
regional lymph nodes (45). These in vivo findings
arecompatiblewithearlierobservationsofKasprzak
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ometry to elucidate the dissolution of a-Ni3S2
duringinvitroincubation inrat serum. a-Ni3S2 was
slowly oxidized to crystalline nickel monosulfide
(,3-NiS), which subsequently underwent further
oxidation to yield soluble Ni(II) complexes and
relatively insoluble particles of nickel hydroxide
[Ni(OH)2] (44).
Electron Microscopic Studies
Bruni (48) administered a-Ni3S2 to male Spra-
gue-Dawley rats by unilateral or bilateral IM
injection into the thigh muscles (20 mg/injection).
The rats were sacrificed at intervals from 2 to 26
weeks, and tissue from the injection site was
examined by electron microscopy. Mitotic activity
was seen primarily in muscle satellite cells. Satel-
lite cells in division were morphologically indistin-
guishablefromdividingstemcellsina-Ni3S2-induced
rhabdomyosarcomas. On thebasis ofthese findings,
Bruni (48) suggested that muscle satellite cells are
progenitors of the a-Ni3S2-induced tumors.
Hildebrand and Biserte (49) performed electron
microscopy of 12 rhabdomyosarcomas that were
induced in an unspecified number ofWistar rats by
IM implantation of a-Ni3S2 in agar (20 mg a-
Ni3S2/rat). Successive stages of differentiation of
tumor cells were described, and formation of
microtubules in interphase rhabdomyoblasts was
convincingly demonstrated. Hildebrand and Biserte
(49) did not -observe any satellite cells in the
rhabdomyosarcomas. In another study, Hildebrand
andBiserte (35)describedcylindricalparacrystalline
structuresinrhabdomyoblasts ofrhabdomyosarcomas
that were induced in rabbits by IM injection of
a-Ni3S2 in agar(80mga-Ni3S2/rabbit). The authors
speculated that the laminated cylindrical bodies
represented abnormal aggregates of contractile
proteins that were synthesized during myofibrillar
differentiation.
Jasmin et al. (50) treated 25 female Sprague-
Dawleyratsby IR injection ofa-Ni3S2 inglycerol (5
mg a-Ni3S2/rat). Groups of five rats were killed at
biweekly intervals until 2 months, and the injected
kidneys were examined by electron microscopy.
Unusual crystalline inclusions were observed in
mitochondria of tubular cells that were located in
thepars rectaofthe distalnephron. Bygoniometric
analysis, the authors deduced that the crystalline
inclusions were composed of cylindrical rods in a
hexagonal array. Jasmin et al. (50) speculated that
the crystalline inclusions might consist ofabnormal
assemblages ofprotein components ofmitochondri-
al cristae.
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Cytogenetic and Tumor Transplantation
Studies
Yamashiro et al. (51) performed karyotypic anal-
yses and transplantation experiments on rhabdo-
myosarcomas that were induced in Fischer and
Long-Evans rats by single IM injection of a-Ni3S2
(10mg/rat). Thechromosomalcomplementsoftumor
cells from 12 primary rhabdomyosarcomas were
usually in the diploid range, although 11 of the 12
tumors contained afew triploid and tetraploid cells.
Abnormal chromosomes were found, including
dicentric, triradial, and ring forms. Comparisons of
chromosomes ofprimary and metastatic tumorcells
suggested that tumors with diploid or near-diploid
chromosomes were most likely to metastasize.
Rhabdomyosarcoma cells were cultured in vivo in
diffusion chambers which were implanted in the
peritoneal cavity of syngeneic rats. Such cell cul-
tures exhibited less myogenic differentiation than
parallel cell cultures which were incubated in vitro
in Leighton tubes (51).
Abandowitz (52) added neuraminidase to cul-
turedcellsfromana-Ni3S2-inducedratfibrosarcoma.
Theneuraminidase treatmentinhibitedtumorgrowth
following inoculation of the fibroblasts into normal
recipient rats. The recipient rats acquired enhanced
resistance to subsequent inoculations of tumor
cells.
Effects on DNA Synthesis in Vivo
Hui and Sunderman (53) measured in vivo incor-
poration ofthymidine-3H into DNA in rats at 28 hr
after partial hepatectomy. Administration ofnickel
carbonyl [Ni(CO)4] at 2 or 4 hr before sacrifice
inhibited thymidine-3H uptakeinto liverand kidney
DNA. For example, in rats killed 4 hr after IV
injection ofNI(CO)4 (2 mg Ni/100 g), 3H-labeling of
liver DNA averaged 54 (SE ± 10) % of controls,
and 3H-labeling ofkidney DNA averaged 53 ± 6 %
ofcontrols. Injection ofNiC12 (2 mg Ni/100 g, im) 4
hr before sacrifice did not significantly affect
thymidine-3H uptake into liver DNA, but did inhib-
it thymidine-3H uptake into kidney DNA (65 ± 6%
of controls). Binding of 'Ni to DNA in liver and
kidneyofrats killed 4 hrafterinjection of63Ni(CO)4
or E3NiCl2 ranged from 0.3 to 2.2 mole 'Ni/mole of
DNA nucleotides. The binding of 'Ni to DNA that
was observed by Hui and Sunderman (53) was
consistent with previous reports by Heath and
Webb (54) and Webb et al. (55) ofnickel binding to
nucleoli, chromatin, and deoxyribonucleohistones
isolated from nickel-induced rhabdomyosarcomas.
However, thepresence of'Niinthe DNAprepara-
137tions did not necessarily connote in vivo 63Ni-
binding, since the possibility of 63Ni-binding to
DNA during tissue homogenization and DNA isola-
tion could not be excluded (53). Hui and Sunderman
performed ultracentrifugal fractionations of liver
DNA on alkaline sucrose gradients (53), and they
did not observe any differences between sedimen-
tation profiles of liver DNA from Ni(CO)4-treated
rats versus paired control rats.
Relevant Studies in Cell Cultures
In vitro exposure of mammalian cells to certain
nickel compounds inhibits cellular uptake of
thymidine-3H andinduces chromosomalaberrations,
somatic mutations, and morphological transforma-
tion. In studies which were briefly mentioned in the
NAS and IARC monographs (1, 2), Basrur and
Gilman (56) and Swierenga and Basrur (57) showed
that addition of a-Ni3S2 to cultures of rat embryo
muscle cells profoundly inhibited thymidine-3H up-
take, suppressed cell division, and induced bizarre
mitoses, including multipolar and distorted bipolar
spindles, C-metaphase-like shapes, and lagging
chromosomes. Mitotic arrest occurred in telophase
and post-telophase, consistent with disturbed disso-
lutionofmitoticspindles. Inarecentstudy, Nishimura
and Umeda (58) found that addition of nickel
compounds, (NiC12, NiS, nickel acetate, and potas-
siumcyanonickelate), toculturesofmousemammary
carcinoma cells inhibited thymidine-3H uptake and
increased the frequency of chromosomal aberra-
tions. Anacher and Paillet (59) reported that expo-
sure of mouse lymphoma cells to NiCl2 caused
dose-dependent increases in trifluorothymidine-
resistant mutants, and Hsie et al. (60) noted that
exposure of Chinese hamster ovary cells to NiC12
induced thioguanine-resistant mutants. Casto et al.
(61), DiPaolo and Casto (62), Pienta et al. (63),
Costa et al. (64-66), and Rivedal and Sanner (67)
showed that in vitro exposures of Syrian hamster
embryo cells to NiSO4 or a-Ni3S2 resulted in
morphological transformation. Casto et al. (61)
failed to detect DNA damage by alkaline sucrose
gradient ultracentrifugation of DNA from cultured
hamster embryo cells that had been exposed in
vitro to NiSO4. Costa et al. (66) demonstrated that
several clones of a-Ni3S2-transformed cells pro-
duced fibrosarcomas following SC injection in nude
mice. DiPaolo and Casto (62) and Costa et al. (66)
observed dose-dependent relationships between the
concentration ofa-Ni3S2 in the tissue culture medi-
um and the incidence ofmorphological transforma-
tionofSyrian hamsterfetal cells. Amorphous nickel
monosulfide (NiS) did not induce morphological
transformation under the same conditions (62, 66).
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Costa et al. (67) compared in vitro uptake of
ot-Ni3S2 and amorphous NiS by Chinese hamster
ovary cells and Syrian hamster fetal cells. Both
types of cells avidly engulfed a-Ni3S2 particles,
whereas they only engulfed a few amorphous NiS
particles under similar exposure conditions. Costa
et al. (67) suggested that the striking disparity in
carcinogenic activity of crystalline a-Ni3S2 and
amorphous NiS may be attributed to marked dif-
ferences in cellular uptake of the two compounds.
Rivedal and Sanner (68) employed in vitro mor-
phological transformation and induction of somatic
mutation to investigate synergism between nickel
and polycyclic aromatic hydrocarbons. The trans-
formation frequency of Syrian hamster embryo
cells increased with increasing concentrations of
NiSO4, benzo(a)pyrene (BP), ormethylcholanthrene
(MC). When cells were exposed to combinations of
NiSO4 and BP, the transformation frequencies
were much higher than when the compounds were
tested separately. The greatest enhancement was
foundwith5 ,ug/mlofNiSO4- 6H20and0.78jig/mlof
BP. The transformation frequency obtained with
this combination was 10.7%, compared to frequen-
cies of 0.5% and 0.6% that were obtained with the
individual substances. No synergistic effect was
detected between NiSO4 and MC. In experiments
thatmeasured somaticmutationsin Syrianhamster
embryo cells by selection for ouabain-resistance,
the mutation frequency was significantly higher
than expected when the cells were exposed to
mixturesofNiSO4andBP(68). Rivedaland Sanner's
observation ofmutagenic synergism between NiSO4
and BP is consistent with an earlier report by
Maenza et al. (69) of carcinogenic synergism be-
tween a-Ni3S2 and BP following IM injection in
Fischer rats. Sunderman (70) observed that expo-
sure ofrats to Ni(CO)4 by inhalation or IV injection
inhibited phenothiazine induction of BP (arylhy-
drocarbon) hydroxylase activity in lung and liver.
Sunderman and Roszel (71) administered BPto rats
by IV injection and studied the effect ofNi(CO)4 on
the retention of BP in lung and liver. A single
exposure ofrats to Ni(CO)4 inhibited BP mobiliza-
tion from lung and liver for 48 hr (70). The
inhibitory effects of nickel compounds on BP me-
tabolism are of especial interest in view of the
potentiating effect of cigarette smoking on the
development oflungcancerin nickel refinery work-
ers (12, 13, 16).
Mutagenicity Tests in Bacteria
Bacterial mutagenesis tests of nickel compounds
have consistently been negative, despite several
attempts by experienced workers to demonstrate
Environmental Health Perspectivesmutagenicity in E. coli or S. typhimurium (7,
72-75).*
Studies in Biochemical Systems
Sirover and Loeb (77) demonstrated that Ni(II),
Co(II), and Mn(II) substituted for Mg(II) as activa-
tors of avian myeloblastosis virus (AMV) DNA
polymerase forreplication ofsynthetic polynucleotide
templates. During DNA synthesis by AMV DNA
polymerase in the presence of Mg(II), addition of
Ni(II) (as well as soluble salts ofother carcinogenic
metals) decreased the fidelity of DNA replication
(77, 78). Sirover and Loeb (78) suggested that
impaired fidelity ofDNA replication by AMV DNA
polymerase might serve as an in vitro screening
test to identify metal compounds that could poten-
tially be carcinogenic and/or mutagenic. Miyaki et
al. (79) found that Ni(II) increased misincorporation
of deoxynucleotides by E. coli DNA polymerase I
during transcription of synthetic polynucleotide
templates. Loeb et al. (80) and Zakour et al. (81)
speculated that carcinogenic metals may diminish
the fidelity of DNA polymerase activity in target
cells in vivo, and may thereby induce errors in
selection of nucleotide bases during DNA synthe-
sis. According to this hypothesis, decreased fidelity
of DNA polymerase might initiate a cascade of
random somatic mutations and evolve transformed
cells that possess selective advantages for prolifera-
tion in the host. This hypothesis and related theo-
ries about possible molecular mechanisms of metal
carcinogenesis have been considered in recent re-
view articles (7, 75, 81, 82).
Prospects for Future Research
The demonstration by Sirover and Loeb (80) of
metal-induced infidelity of DNA replication may
possiblypoint to a fundamental mechanism ofmetal
carcinogenesis. However, even if this is not the
case, their research has attracted the attention of
molecular biologists to the previously neglected
areaofmetalcarcinogenesis. Recent refinements of
techniques to investigate derangements of nucleic
acid synthesis, repair, and regulation in eukaryotic
cells will undoubtedly facilitate mechanistic studies
ofmetal carcinogenesis. (x-Ni3S2 is an exceptionally
*Dr. SamuelJ. Rogers (MontanaStateCollege, Bozeman, MT)
did not observe mutations of S. typhimurium in the Ames
mutagenesis test system with a-Ni3S2, NiS, Ni3S4, NiTe, NiSb,
NiO, and NiSO4, (personal communications on December3, 1976
and January 26, 1977). Dr. Goran Lofroth (University of
California, Berkeley, CA) also obtained negative results in the
Ames mutagenesis test system with a-Ni3S2, (personal commu-
nication on March 3, 1977).
advantageous compound for use in such studies,
since a-Ni3S2 is inexpensively available in high
purity and is readily labelled with 63Ni, a beta-
emitting radioisotope with long half-life that is well
suited for liquid scintillation counting and autoradi-
ography. The carcinogenic activity of a-Ni3S2 is
apparently greater than any other metallic com-
pound which has been investigated (6). A remark-
ablevarietyofanimalspecies, routesofadministration
and cell culture systems can be employed forcancer
research with a-Ni3S2. Furthermore, neoplastic
transformation by a-Ni3S2 can be suppressed by
manganese dust invivo and invitro (30, 33,40, 64).
This observation may serve as a clue to identify the
biochemical effects of a-Ni3S2 that are specifically
associated with neoplastic transformation.
This work was supported by National Institute of Environ-
mental Health Sciences Grant ES-01337 and U.S. Department of
Energy Grant EV-03140.
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